Apollo Endosurgery Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
APEN Nasdaq 3841 http://apolloendo.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Apollo Endosurgery Inc

Apollo Endosurgery, Inc. Announces Commencement of Public Offering of Common Stock - Jun 19th, 2018 2:00 pm
Apollo Endosurgery Announces Presentation of Mayo Clinic’s Clinical Study of ORBERA® Intragastric Balloon in Patients with Nonalcoholic Steatohepatitis (NASH) at Digestive Disease Week® 2018 (DDW) - Jun 5th, 2018 7:00 am
Apollo Endosurgery Announces Presentation of Mortality and Inpatient Costs of Revisional Bariatric Surgery - Jun 4th, 2018 2:01 pm
Apollo Endosurgery Announces FDA Approval of Revised Labeling for the ORBERA® Intragastric Balloon System - Jun 4th, 2018 11:00 am
Apollo Endosurgery Announces Presentation of Intragastric Balloon Comparison Study at Digestive Disease Week® 2018 titled: “Fluid-Filled Intragastric Balloons are Superior to Gas-Filled Balloon” - Jun 4th, 2018 6:00 am
Apollo Endosurgery Appoints Dr. Julie Shimer to Board of Directors - May 31st, 2018 3:59 pm
Apollo Endosurgery to Feature Industry-Advancing Endoscopic Procedure Portfolio During Digestive Disease Week® 2018 Conference - May 24th, 2018 3:44 pm
Detailed Research: Economic Perspectives on McGrath RentCorp, Universal Forest Products, Venator Materials, Armada Hoffler Properties, Atlantic Coast Financial, and Apollo Endosurgery — What Drives Growth in Today's Competitive Landscape - May 23rd, 2018 5:50 am
Apollo Endosurgery Announces Spanish Study of ESG in NASH Patients - May 14th, 2018 3:00 am
Apollo Endosurgery Establishes European Registry for Bariatric Flexible Endoscopic Suturing Procedures - May 8th, 2018 2:01 pm
Free Post Earnings Research Report: Edwards Lifesciences’ Adjusted Sales Grew 9.3%; Adjusted EPS Surged 30% - May 8th, 2018 5:40 am
Apollo Endosurgery, Inc. Reports First Quarter 2018 Results - May 3rd, 2018 2:01 pm
Apollo Endosurgery, Inc. to Report First Quarter Results on May 3, 2018 - Apr 26th, 2018 2:01 pm
Apollo Endosurgery Announces Approval of the New 12-month Weight Loss Balloon - ORBERA365™ - in the Kingdom of Saudi Arabia - Apr 23rd, 2018 2:01 pm
Analysis: Positioning to Benefit within Aerojet Rocketdyne, Summit Hotel Properties, Apollo Endosurgery, The KEYW Holding, FARO Technologies, and Tilly's — Research Highlights Growth, Revenue, and Consolidated Results - Mar 30th, 2018 5:50 am
Apollo Endosurgery Announces Conclusion of LAP-BAND® Low BMI Post-Approval Study - Mar 12th, 2018 4:10 pm
Blog Exposure - FDA Approves First Automated Robotic Movement in technIQ(TM) Series for Corindus’ CorPath GRX Platform - Mar 7th, 2018 5:30 am
Apollo Endosurgery, Inc. to Participate at the 30th Annual ROTH Conference - Mar 5th, 2018 2:05 pm
Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2017 Results - Mar 1st, 2018 2:01 pm
Apollo Endosurgery Announces First ORBERA® U.S. Post-Approval Publication - Feb 26th, 2018 3:27 pm